Related Experiment Video

Updated: Jul 3, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Vascular disease risk factors and findings in patients with Alzheimer's disease

P Tariska1, V Klein, G Pánczél

  • 1Memory Clinic, National Institute of Psychiatry and Neurology, Budapest, 1281 Budapest 27 POB 1, Hungary.

Archives of Gerontology and Geriatrics
|July 26, 2008
PubMed

Insights

Vascular risk factors and extracerebral vascular changes were studied in dementia patients. While marked changes were seen in vascular dementia, no significant differences were found between probable Alzheimer's disease and other forms.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Dementia, including Alzheimer's disease and vascular dementia, is a growing public health concern.
  • Vascular risk factors are increasingly recognized as potential contributors to cognitive decline.
  • Understanding the interplay between vascular health and different dementia subtypes is crucial for effective management.

Purpose of the Study:

  • To analyze vascular risk factors and extracerebral vascular conditions in patients with dementia.
  • To investigate the prevalence and characteristics of vascular alterations in probable Alzheimer's disease, vascular dementia, and mixed dementia.
  • To explore potential correlations between vascular findings and dementia severity.

Main Methods:

  • Data from demented patients admitted to a Memory Clinic were collected.
  • Three key vascular examinations were performed: Electrocardiogram (ECG), Doppler ultrasound of extracerebral arteries, and ophthalmoneurological examination.
  • Risk factors and vascular alterations were analyzed and condensed into two main factors.

Main Results:

  • No statistically significant differences in descriptive data or the two derived factors were observed between probable Alzheimer's disease, vascular dementia, and mixed dementia groups.
  • Vascular risk factors and pathological changes were found to be present in probable Alzheimer's disease, including early-onset forms.
  • The most pronounced vascular changes were observed in the vascular dementia group, though correlations between findings and severity were lacking.

Conclusions:

  • Vascular risk factors and subclinical pathological changes can be present in Alzheimer's disease, even in early stages.
  • While vascular dementia shows the most significant vascular alterations, the relationship between different vascular findings and their severity requires further investigation.
  • The high prevalence of cardiovascular and cerebrovascular disease in Hungary may influence these findings, highlighting the need for further research into vascular contributions to dementia.

More Related Videos

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.